APA
Lee P. C. H., Gu Y., Yeung M. Y., Fong C. H. Y., Woo Y. C., Chow W. S., Tan K. & Lam K. S. L. (2018). Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study. : Diabetes therapy : research, treatment and education of diabetes and related disorders.
Chicago
Lee Paul Chi Ho, Gu Yunjuan, Yeung Man Yi, Fong Carol Ho Yi, Woo Yu Cho, Chow Wing Sun, Tan Kathryn and Lam Karen Siu Ling. 2018. Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study. : Diabetes therapy : research, treatment and education of diabetes and related disorders.
Harvard
Lee P. C. H., Gu Y., Yeung M. Y., Fong C. H. Y., Woo Y. C., Chow W. S., Tan K. and Lam K. S. L. (2018). Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study. : Diabetes therapy : research, treatment and education of diabetes and related disorders.
MLA
Lee Paul Chi Ho, Gu Yunjuan, Yeung Man Yi, Fong Carol Ho Yi, Woo Yu Cho, Chow Wing Sun, Tan Kathryn and Lam Karen Siu Ling. Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study. : Diabetes therapy : research, treatment and education of diabetes and related disorders. 2018.